Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Center Bancorp
CNOB
$1.81B
| $1.28M | ﹤0.01% |
52,722
+10,357
| +24% | +$255K |
|
2552
Renasant Corp
RNST
$4.03B
| $1.27M | ﹤0.01% |
33,882
+15,021
| +80% | +$568K |
|
2553
Marti Technologies
MRT
$154M
| $1.27M | ﹤0.01% |
124,860
| – | – |
|
|
ITAQW
2554
DELISTED
Industrial Tech Acquisitions II, Inc. Warrants
ITAQW
| $1.27M | ﹤0.01% |
125,000
| – | – |
|
2555
Arcosa
ACA
$7.14B
| $1.27M | ﹤0.01% |
23,411
+3,034
| +15% | +$180K |
|
2556
Pyxis Oncology
PYXS
$198M
| $1.27M | ﹤0.01% |
948,051
+400
| +0% | +$600 |
|
2557
Valaris
VAL
$5.33B
| $1.27M | ﹤0.01% |
18,780
-8,538
| -31% | -$533K |
|
2558
Fortis
FTS
$28.8B
| $1.27M | ﹤0.01% |
31,712
-44,492
| -58% | -$1.74M |
|
2559
Encompass Health
EHC
$11B
| $1.27M | ﹤0.01% |
21,221
-8,022
| -27% | -$436K |
|
2560
FirstCash
FCFS
$9.02B
| $1.27M | ﹤0.01% |
14,591
-645
| -4% | -$57.1K |
|
|
FAAS
2561
DELISTED
DigiAsia
FAAS
| $1.27M | ﹤0.01% |
123,475
| – | – |
|
2562
Eastern Bankshares
EBC
$5.31B
| $1.26M | ﹤0.01% |
73,192
+14,247
| +24% | +$273K |
|
|
WQGA
2563
DELISTED
World Quantum Growth Acquisition Corp.
WQGA
| $1.26M | ﹤0.01% |
123,761
| – | – |
|
|
CMRX
2564
DELISTED
Chimerix, Inc.
CMRX
| $1.26M | ﹤0.01% |
677,982
+251,128
| +59% | +$491K |
|
2565
Crinetics Pharmaceuticals
CRNX
$8.91B
| $1.26M | ﹤0.01% |
68,843
+18,238
| +36% | +$321K |
|
|
OZON
2566
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
| $1.26M | ﹤0.01% |
108,532
| – | – |
|
|
ALE
2567
DELISTED
Allete
ALE
| $1.26M | ﹤0.01% |
19,510
+8,823
| +83% | +$523K |
|
2568
Sally Beauty Holdings
SBH
$1.48B
| $1.26M | ﹤0.01% |
100,260
+25,262
| +34% | +$310K |
|
2569
Moelis & Co
MC
$5.14B
| $1.25M | ﹤0.01% |
32,653
-26,514
| -45% | -$1.08M |
|
2570
AnaptysBio
ANAB
$1.63B
| $1.25M | ﹤0.01% |
40,351
-8,422
| -17% | -$238K |
|
|
ERF
2571
DELISTED
Enerplus Corporation
ERF
| $1.25M | ﹤0.01% |
70,809
-16,686
| -19% | -$286K |
|
2572
Apogee Enterprises
APOG
$897M
| $1.25M | ﹤0.01% |
28,077
+1,178
| +4% | +$53.1K |
|
2573
1st Source
SRCE
$2.17B
| $1.25M | ﹤0.01% |
23,503
+429
| +2% | +$23.4K |
|
2574
Sunoco
SUN
$13.8B
| $1.25M | ﹤0.01% |
28,919
+5,828
| +25% | +$246K |
|
2575
O-I Glass
OI
$1.15B
| $1.25M | ﹤0.01% |
75,168
+33,789
| +82% | +$544K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.